The DOI matches its Crossref record; 92 of the 92 references it cites were found in a registry or an index.
Tumour‐associated microglia/macrophages predict poor prognosis in high‐grade gliomas and correlate with an aggressive tumour subtype
Open accessAbstract
Aims: Glioblastomas are highly aggressive and treatment resistant. Increasing evidence suggests that tumour‐associated macrophages/microglia (TAMs) facilitate tumour progression by acquiring a M2‐like phenotype. Our objective was to investigate the prognostic value of TAMs in gliomas using automated quantitative double immunofluorescence. Methods: Samples from 240 patients with primary glioma were stained with antibodies against ionized calcium‐binding adaptor molecule‐1 (IBA‐1) and cluster of differentiation 204 (CD204) to detect TAMs and M2‐like TAMs. The expression levels were quantified by software‐based classifiers. The associations between TAMs, gemistocytic cells and glioblastoma subtype were examined with immuno‐ and haematoxylin–eosin stainings. Three tissue arrays containing glioblastoma specimens were included to study IBA‐1/CD204 levels in central tumour and tumour periphery and to characterize CD204+ cells. Results: Our data revealed that the amount of especially CD204+ TAMs increases with malignancy grade. In grade III–IV, high CD204 expression was associated with shorter survival, while high IBA‐1 intensity correlated with a longer survival. In grade IV, CD204 showed independent prognostic value when adjusting for clinical data and the methylation status of O6‐methylguanine–DNA methyltransferase. Our findings were confirmed in two bioinformatics databases. TAMs were more abundant in central tumour tissue, mesenchymal glioblastomas and gliomas with many gemistocytic cells. CD204+ TAMs co‐expressed proteins related to tumour aggressiveness including matrix metallopeptidase‐14 and hypoxia‐inducible factor‐1α. Conclusions: This is the first study to use automated quantitative immunofluorescence to determine the prognostic impact of TAMs. Our results suggest that M2‐like TAMs hold an unfavourable prognostic value in high‐grade gliomas and may contribute to a pro‐tumourigenic microenvironment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Radiotherapy Plus Concomitant and Adjuvant Temozolomide for Glioblastoma
Stupp, R., Mason, W. P., van den Bent, M. J., Weller, M., Fisher, B., Taphoorn, M. J. B., Belanger, K., Brandes, A. A., Marosi, C., Bogdahn, U., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043330 · Cited by 21,807
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
The Cancer Genome Atlas Research Network (2008) · Nature · doi:10.1038/nature07385 · Cited by 7,735
Stupp, R., Hegi, M. E., Mason, W. P., van den Bent, M. J., Taphoorn, M. J., Janzer, R. C., Ludwin, S. K., Allgeier, A., Fisher, B., Belanger, K., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70025-7 · Cited by 7,668
The chemokine system in diverse forms of macrophage activation and polarization
MANTOVANI, A., SICA, A., SOZZANI, S., ALLAVENA, P., VECCHI, A., & LOCATI, M. (2004) · Trends in Immunology · doi:10.1016/j.it.2004.09.015 · Cited by 6,534
Phillips, H. S., Kharbanda, S., Chen, R., Forrest, W. F., Soriano, R. H., Wu, T. D., Misra, A., Nigro, J. M., Colman, H., Soroceanu, L., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.02.019 · Cited by 3,143
Ceccarelli, M., Barthel, F. P., Malta, T. M., Sabedot, T. S., Salama, S. R., Murray, B. A., Morozova, O., Newton, Y., Radenbaugh, A., Pagnotta, S. M., et al. (2016) · Cell · doi:10.1016/j.cell.2015.12.028 · Cited by 2,189
Wang, Q., Hu, B., Hu, X., Kim, H., Squatrito, M., Scarpace, L., deCarvalho, A. C., Lyu, S., Li, P., Li, Y., et al. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.06.003 · Cited by 1,995
Microglia-specific localisation of a novel calcium binding protein, Iba1
Ito, D., Imai, Y., Ohsawa, K., Nakajima, K., Fukuuchi, Y., & Kohsaka, S. (1998) · Molecular Brain Research · doi:10.1016/s0169-328x(98)00040-0 · Cited by 1,476
Sica, A., Schioppa, T., Mantovani, A., & Allavena, P. (2006) · European Journal of Cancer · doi:10.1016/j.ejca.2006.01.003 · Cited by 1,451
Mesenchymal Differentiation Mediated by NF-κB Promotes Radiation Resistance in Glioblastoma
Bhat, K. P. L., Balasubramaniyan, V., Vaillant, B., Ezhilarasan, R., Hummelink, K., Hollingsworth, F., Wani, K., Heathcock, L., James, J. D., Goodman, L. D., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.08.001 · Cited by 1,102
Dose-Dense Temozolomide for Newly Diagnosed Glioblastoma: A Randomized Phase III Clinical Trial
Gilbert, M. R., Wang, M., Aldape, K. D., Stupp, R., Hegi, M. E., Jaeckle, K. A., Armstrong, T. S., Wefel, J. S., Won, M., Blumenthal, D. T., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2013.49.6968 · Cited by 1,063
Zhang, Q.-W., Liu, L., Gong, C.-Y., Shi, H.-S., Zeng, Y.-H., Wang, X.-Z., Zhao, Y.-W., & Wei, Y.-Q. (2012) · PLoS ONE · doi:10.1371/journal.pone.0050946 · Cited by 1,039
Imai, Y., Ibata, I., Ito, D., Ohsawa, K., & Kohsaka, S. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.1112 · Cited by 872
Possible involvement of the M2 anti‐inflammatory macrophage phenotype in growth of human gliomas
Komohara, Y., Ohnishi, K., Kuratsu, J., & Takeya, M. (2008) · The Journal of Pathology · doi:10.1002/path.2370 · Cited by 738
The brain tumor microenvironment
Charles, N. A., Holland, E. C., Gilbertson, R., Glass, R., & Kettenmann, H. (2011) · Glia · doi:10.1002/glia.21136 · Cited by 718
The brain tumor microenvironment
Charles, N. A., Holland, E. C., Gilbertson, R., Glass, R., & Kettenmann, H. (2012) · Glia · doi:10.1002/glia.21264 · Cited by 712
Glioma cancer stem cells induce immunosuppressive macrophages/microglia
Wu, A., Wei, J., Kong, L.-Y., Wang, Y., Priebe, W., Qiao, W., Sawaya, R., & Heimberger, A. B. (2010) · Neuro-Oncology · doi:10.1093/neuonc/noq082 · Cited by 691
Intrinsic Gene Expression Profiles of Gliomas Are a Better Predictor of Survival than Histology
Gravendeel, L. A. M., Kouwenhoven, M. C. M., Gevaert, O., de Rooi, J. J., Stubbs, A. P., Duijm, J. E., Daemen, A., Bleeker, F. E., Bralten, L. B. C., Kloosterhof, N. K., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-2307 · Cited by 678
Much More than M1 and M2 Macrophages, There are also CD169+ and TCR+ Macrophages
Chávez-Galán, L., Olleros, M. L., Vesin, D., & Garcia, I. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00263 · Cited by 653
Taylor, C. R., & Levenson, R. M. (2006) · Histopathology · doi:10.1111/j.1365-2559.2006.02513.x · Cited by 609
Macrophage Polarisation: an Immunohistochemical Approach for Identifying M1 and M2 Macrophages
Barros, M. H. M., Hauck, F., Dreyer, J. H., Kempkes, B., & Niedobitek, G. (2013) · PLoS ONE · doi:10.1371/journal.pone.0080908 · Cited by 594
The role of human glioma-infiltrating microglia/macrophages in mediating antitumor immune responses1
Hussain, S. F., Yang, D., Suki, D., Aldape, K., Grimm, E., & Heimberger, A. B. (2006) · Neuro-Oncology · doi:10.1215/15228517-2006-008 · Cited by 592
MGMT testing—the challenges for biomarker-based glioma treatment
Wick, W., Weller, M., van den Bent, M., Sanson, M., Weiler, M., von Deimling, A., Plass, C., Hegi, M., Platten, M., & Reifenberger, G. (2014) · Nature Reviews Neurology · doi:10.1038/nrneurol.2014.100 · Cited by 579
Zhang, M., He, Y., Sun, X., Li, Q., Wang, W., Zhao, A., & Di, W. (2014) · Journal of Ovarian Research · doi:10.1186/1757-2215-7-19 · Cited by 528
Ye, X.-Z., Xu, S.-L., Xin, Y.-H., Yu, S.-C., Ping, Y.-F., Chen, L., Xiao, H.-L., Wang, B., Yi, L., Wang, Q.-L., et al. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1103248 · Cited by 477
Hypoxia Regulates Macrophage Functions in Inflammation
Murdoch, C., Muthana, M., & Lewis, C. E. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.10.6257 · Cited by 455
Edin, S., Wikberg, M. L., Dahlin, A. M., Rutegård, J., Öberg, Å., Oldenborg, P.-A., & Palmqvist, R. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047045 · Cited by 454
Glioblastoma-infiltrated innate immune cells resemble M0 macrophage phenotype
Gabrusiewicz, K., Rodriguez, B., Wei, J., Hashimoto, Y., Healy, L. M., Maiti, S. N., Thomas, G., Zhou, S., Wang, Q., Elakkad, A., et al. (2016) · JCI Insight · doi:10.1172/jci.insight.85841 · Cited by 445
Coniglio, S. J., Eugenin, E., Dobrenis, K., Stanley, E. R., West, B. L., Symons, M. H., & Segall, J. E. (2012) · Molecular Medicine · doi:10.2119/molmed.2011.00217 · Cited by 428
Macrophage Responses to Hypoxia
Lewis, C., & Murdoch, C. (2005) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)62038-x · Cited by 413
Laoui, D., Van Overmeire, E., Di Conza, G., Aldeni, C., Keirsse, J., Morias, Y., Movahedi, K., Houbracken, I., Schouppe, E., Elkrim, Y., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-1196 · Cited by 412
Szulzewsky, F., Pelz, A., Feng, X., Synowitz, M., Markovic, D., Langmann, T., Holtman, I. R., Wang, X., Eggen, B. J. L., Boddeke, H. W. G. M., et al. (2015) · PLOS ONE · doi:10.1371/journal.pone.0116644 · Cited by 406
Gliomas induce and exploit microglial MT1-MMP expression for tumor expansion
Markovic, D. S., Vinnakota, K., Chirasani, S., Synowitz, M., Raguet, H., Stock, K., Sliwa, M., Lehmann, S., Kälin, R., van Rooijen, N., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804273106 · Cited by 391
Mechanisms of Chemoresistance to Alkylating Agents in Malignant Glioma
Sarkaria, J. N., Kitange, G. J., James, C. D., Plummer, R., Calvert, H., Weller, M., & Wick, W. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1719 · Cited by 373
Intracellular signaling in M‐CSF‐induced microglia activation: Role of Iba1
Imai, Y., & Kohsaka, S. (2002) · Glia · doi:10.1002/glia.10149 · Cited by 359
Husemann, J., Loike, J. D., Anankov, R., Febbraio, M., & Silverstein, S. C. (2002) · Glia · doi:10.1002/glia.10148 · Cited by 358
The molecular profile of microglia under the influence of glioma
Li, W., & Graeber, M. B. (2012) · Neuro-Oncology · doi:10.1093/neuonc/nos116 · Cited by 340
Chemoresistance of glioblastoma cancer stem cells - much more complex than expected
Beier, D., Schulz, J. B., & Beier, C. P. (2011) · Molecular Cancer · doi:10.1186/1476-4598-10-128 · Cited by 312
Joseph, J. V., Conroy, S., Pavlov, K., Sontakke, P., Tomar, T., Eggens-Meijer, E., Balasubramaniyan, V., Wagemakers, M., den Dunnen, W. F. A., & Kruyt, F. A. E. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.01.010 · Cited by 302
Nishie, A., Ono, M., Shono, T., Fukushi, J., Otsubo, M., Onoue, H., Ito, Y., Inamura, T., 清信, 池., Fukui, M., et al. (1999) · PubMed · Cited by 301
Herrera, M., Herrera, A., Domínguez, G., Silva, J., García, V., García, J. M., Gómez, I., Soldevilla, B., Muñoz, C., Provencio, M., et al. (2013) · Cancer Science · doi:10.1111/cas.12096 · Cited by 289
Flow Cytometric Characterization of Tumor-associated Macrophages in Experimental Gliomas
Badie, B., & Schartner, J. M. (2000) · Neurosurgery · doi:10.1097/00006123-200004000-00035 · Cited by 278
Macrophage Infiltration and Heme Oxygenase-1 Expression Correlate with Angiogenesis in Human Gliomas
西江, 昭. (2001) · Medical Entomology and Zoology · doi:10.11501/3181003 · Cited by 278
Helm, O., Held‐Feindt, J., Grage‐Griebenow, E., Reiling, N., Ungefroren, H., Vogel, I., Krüger, U., Becker, T., Ebsen, M., Röcken, C., et al. (2014) · International Journal of Cancer · doi:10.1002/ijc.28736 · Cited by 260
Piao, Y., Liang, J., Holmes, L., Zurita, A. J., Henry, V., Heymach, J. V., & de Groot, J. F. (2012) · Neuro-Oncology · doi:10.1093/neuonc/nos158 · Cited by 227
Immune Heterogeneity of Glioblastoma Subtypes: Extrapolation from the Cancer Genome Atlas
Doucette, T., Rao, G., Rao, A., Shen, L., Aldape, K., Wei, J., Dziurzynski, K., Gilbert, M., & Heimberger, A. B. (2013) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-13-0028 · Cited by 226
Microglial immunophenotype in dementia with Alzheimer’s pathology
CFAS, M., Minett, T., Classey, J., Matthews, F. E., Fahrenhold, M., Taga, M., Brayne, C., Ince, P. G., Nicoll, J. A. R., & Boche, D. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0601-z · Cited by 219
Glioma Grade Is Associated with the Accumulation and Activity of Cells Bearing M2 Monocyte Markers
Prosniak, M., Harshyne, L. A., Andrews, D. W., Kenyon, L. C., Bedelbaeva, K., Apanasovich, T. V., Heber-Katz, E., Curtis, M. T., Cotzia, P., & Hooper, D. C. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-1940 · Cited by 203
Rutledge, W. C., Kong, J., Gao, J., Gutman, D. A., Cooper, L. A. D., Appin, C., Park, Y., Scarpace, L., Mikkelsen, T., Cohen, M. L., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-0551 · Cited by 200
Zhang, J., Sarkar, S., Cua, R., Zhou, Y., Hader, W., & Yong, V. W. (2012) · Carcinogenesis · doi:10.1093/carcin/bgr289 · Cited by 196
Perinatal tolerance to proinsulin is sufficient to prevent autoimmune diabetes
Jhala, G., Chee, J., Trivedi, P. M., Selck, C., Gurzov, E. N., Graham, K. L., Thomas, H. E., Kay, T. W. H., & Krishnamurthy, B. (2016) · JCI Insight · doi:10.1172/jci.insight.86065 · Cited by 193
Shigeoka, M., Urakawa, N., Nakamura, T., Nishio, M., Watajima, T., Kuroda, D., Komori, T., Kakeji, Y., Semba, S., & Yokozaki, H. (2013) · Cancer Science · doi:10.1111/cas.12188 · Cited by 183
Wang, S.-C., Hong, J.-H., Hsueh, C., & Chiang, C.-S. (2012) · Laboratory Investigation · doi:10.1038/labinvest.2011.128 · Cited by 174
Glioma-initiating cells: A predominant role in microglia/macrophages tropism to glioma
Liang, Y., Xiao, H., Xu, M., Ye, X.-Z., Hu, J., Li, F., Li, M., Luo, C., Yu, S., Bian, X., et al. (2010) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2010.10.011 · Cited by 172
Microglia promote glioma migration
Bettinger, I., Thanos, S., & Paulus, W. (2002) · Acta Neuropathologica · doi:10.1007/s00401-001-0472-x · Cited by 165
Scavenger Receptor-A (CD204): A Two-Edged Sword in Health and Disease
Kelley, J. L., Ozment, T. R., Li, C., Schweitzer, J. B., & Williams, D. L. (2014) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.2014010267 · Cited by 159
Glioblastoma: Therapeutic challenges, what lies ahead
Lima, F. R. S., Kahn, S. A., Soletti, R. C., Biasoli, D., Alves, T. R., da Fonseca, A. C. C., Garcia, C., Romão, L. F., Brito, J. M., Afonso, R. C. D. H., et al. (2012) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2012.05.004 · Cited by 150
Yang, Z. F., Ho, D. W., Lau, C. K., Lam, C. T., Lum, C. T., Poon, R. T. P., & Fan, S. T. (2005) · International Immunology · doi:10.1093/intimm/dxh316 · Cited by 138
Importance of direct macrophage ‐ Tumor cell interaction on progression of human glioma
Komohara, Y., Horlad, H., Ohnishi, K., Fujiwara, Y., Bai, B., Nakagawa, T., Suzu, S., Nakamura, H., Kuratsu, J., & Takeya, M. (2012) · Cancer Science · doi:10.1111/cas.12015 · Cited by 136
Impact of tumor‐associated macrophages on invasive ductal carcinoma of the pancreas head
YOSHIKAWA, K., Mitsunaga, S., Kinoshitá, T., Konishi, M., Takahashi, S., Gotohda, N., Kato, Y., Aizawa, M., & Ochiai, A. (2012) · Cancer Science · doi:10.1111/j.1349-7006.2012.02411.x · Cited by 135
Szulzewsky, F., Arora, S., de Witte, L. D., Ulas, T., Markovic, D. S., Schultze, J. L., Holland, E. C., Synowitz, M., Wolf, S. A., & Kettenmann, H. (2016) · Glia · doi:10.1002/glia.23014 · Cited by 120
Innate immune functions of microglia isolated from human glioma patients
Hussain, S. F., Yang, D. S., Suki, D., Grimm, E. A., & Heimberger, A. B. (2006) · Journal of Translational Medicine · doi:10.1186/1479-5876-4-15 · Cited by 109
Karsy, M. J., Gelbman, M., Shah, P., Balumbu, O., MOY, F. H., & Arslan, E. (2012) · Folia Neuropathologica · doi:10.5114/fn.2012.32361 · Cited by 109
Molecular definition of the pro‐tumorigenic phenotype of glioma‐activated microglia
Ellert‐Miklaszewska, A., Dąbrowski, M., Lipko, M. A., Sliwa, M., Maleszewska, M., & Kaminska, B. (2013) · Glia · doi:10.1002/glia.22510 · Cited by 107
Review: Molecular mechanism of microglia stimulated glioblastoma invasion
Coniglio, S. J., & Segall, J. E. (2013) · Matrix Biology · doi:10.1016/j.matbio.2013.07.008 · Cited by 103
Pantano, F., Berti, P., Guida, F. M., Perrone, G., Vincenzi, B., Amato, M., Righi, D., Dell’Aquila, E., Graziano, F., Catalano, V., et al. (2013) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12109 · Cited by 101
Xu, H. M., Rahimpour, S., Nesvick, C. L., Zhang, X., Ma, J., Zhang, M., Zhang, G., Wang, L., Yang, C., Hong, C. S., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.3592 · Cited by 99
MiR-21 expression in the tumor cell compartment holds unfavorable prognostic value in gliomas
Hermansen, S. K., Dahlrot, R. H., Nielsen, B. S., Hansen, S., & Kristensen, B. W. (2012) · Journal of Neuro-Oncology · doi:10.1007/s11060-012-0992-3 · Cited by 89
Self-citationLisi, L., Stigliano, E., Lauriola, L., Navarra, P., & Russo, C. D. (2014) · ASN NEURO · doi:10.1042/an20130045 · Cited by 89
Hirayama, S., Ishii, G., Nagai, K., Ono, S., Kojima, M., Yamauchi, C., Aokage, K., Hishida, T., Yoshida, J., Suzuki, K., et al. (2012) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3182745968 · Cited by 79
Deininger, M., Seid, K., Engel, S., Meyermann, R., & Schluesener, H. J. (2000) · Acta Neuropathologica · doi:10.1007/s004010000233 · Cited by 77
M2 Macrophage/Microglial Cells Induce Activation of Stat3 in Primary Central Nervous System Lymphoma
Komohara, Y., Horlad, H., Ohnishi, K., Ohta, K., Makino, K., Hondo, H., Yamanaka, R., Kajiwara, K., Saito, T., Kuratsu, J., et al. (2011) · Journal of the Japan Society of the Reticuloendothelial System · doi:10.3960/jslrt.51.93 · Cited by 76
High levels of c-Met is associated with poor prognosis in glioblastoma
Petterson, S. A., Dahlrot, R. H., Hermansen, S. K., Munthe, S., Gundesen, M. T., Wohlleben, H., Rasmussen, T., Beier, C. P., Hansen, S., & Kristensen, B. W. (2015) · Journal of Neuro-Oncology · doi:10.1007/s11060-015-1723-3 · Cited by 73
Self-citationExpression and prognostic value of the WEE1 kinase in gliomas
Music, D., Dahlrot, R. H., Hermansen, S. K., Hjelmborg, J., de Stricker, K., Hansen, S., & Kristensen, B. W. (2016) · Journal of Neuro-Oncology · doi:10.1007/s11060-015-2050-4 · Cited by 71
Self-citationChemokine expression profile of freshly isolated human glioblastoma-associated macrophages/microglia
Hattermann, K., Sebens, S., Helm, O., Schmitt, A. D., Mentlein, R., Mehdorn, H. M., & Held‐Feindt, J. (2014) · Oncology Reports · doi:10.3892/or.2014.3214 · Cited by 70
Wang, B., Liu, H., Dong, X., Wu, S., Zeng, H., Liu, Z., Wan, D., Dong, W., He, W., Chen, X., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.3887 · Cited by 59
Prognostic value of Musashi-1 in gliomas
Dahlrot, R. H., Hansen, S., Herrstedt, J., Schrøder, H. D., Hjelmborg, J., & Kristensen, B. W. (2013) · Journal of Neuro-Oncology · doi:10.1007/s11060-013-1246-8 · Cited by 52
Self-citationSugimoto, M., Mitsunaga, S., YOSHIKAWA, K., Kato, Y., Gotohda, N., Takahashi, S., Konishi, M., Ikeda, M., Kojima, M., Ochiai, A., et al. (2014) · European Journal of Cancer · doi:10.1016/j.ejca.2014.04.010 · Cited by 52
Prognostic impact of CD68 and kallikrein 6 in human glioma.
Strojnik, T., Kavalar, R., Zajc, I., Diamandis, E. P., Οικονομοπούλου, Κ., & Lah, T. T. (2009) · PubMed · Cited by 48
Clinical value of CD133 and nestin in patients with glioma: a population-based study.
Dahlrot, R. H., Hansen, S., Jensen, S. S., Schrøder, H. D., Hjelmborg, J., & Kristensen, B. W. (2014) · PubMed · Cited by 43
Self-citationMyeloid cell signatures in tumor microenvironment predicts therapeutic response in cancer
Arbab, A. S., & Achyut, B. R. (2016) · OncoTargets and Therapy · doi:10.2147/ott.s102907 · Cited by 42
Glioma Cells in the Tumor Periphery Have a Stem Cell Phenotype
Munthe, S., Petterson, S. A., Dahlrot, R. H., Poulsen, F. R., Hansen, S., & Kristensen, B. W. (2016) · PLoS ONE · doi:10.1371/journal.pone.0155106 · Cited by 40
Self-citationA population-based study of high-grade gliomas and mutated isocitrate dehydrogenase 1.
Dahlrot, R. H., Kristensen, B. W., Hjelmborg, J., Herrstedt, J., & Hansen, S. (2013) · Europe PMC (PubMed Central) · Cited by 39
Self-citationHuman malignant astrocytes express macrophage phenotype
Leenstra, S., Das, P. K., Troost, D., et al. (1995) · Journal of Neuroimmunology · doi:10.1016/0165-5728(94)00128-b · Cited by 39
A population-based study of low-grade gliomas and mutated isocitrate dehydrogenase 1 (IDH1)
Dahlrot, R. H., Kristensen, B. W., Hjelmborg, J., Herrstedt, J., & Hansen, S. (2013) · Journal of Neuro-Oncology · doi:10.1007/s11060-013-1186-3 · Cited by 36
Self-citationMignogna, C., Signorelli, F., Vismara, M. F. M., Zeppa, P., Camastra, C., Barni, T., Donato, G., & Vito, A. D. (2016) · Pathology - Research and Practice · doi:10.1016/j.prp.2016.02.020 · Cited by 35
Antiinflammatory Properties of IL-10 Rescue Small-for-Size Liver Grafts
Yang, Z. F., Ho, D. W., Ngai, P., Lau, C. K., Zhao, Y., Poon, R. T. P., & Fan, S. T. (2007) · Liver Transplantation · doi:10.1002/lt.21094 · Cited by 32
Chen, D., Bobko, A. A., Gross, A. C., Evans, R., Marsh, C. B., Khramtsov, V. V., Eubank, T. D., & Friedman, A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0107511 · Cited by 30
Pathological findings and prognostic factors in recurrent glioblastomas
Okita, Y., Narita, Y., Miyakita, Y., Ohno, M., Fukushima, S., Kayama, T., & Shibui, S. (2012) · Brain Tumor Pathology · doi:10.1007/s10014-012-0084-2 · Cited by 29
MICROGLIA IN GEMISTOCYTIC ASTROCYTOMAS
Geranmayeh, F., Scheithauer, B. W., Spitzer, C., Meyer, F. B., Svensson-Engwall, A.-C., & Graeber, M. B. (2007) · Neurosurgery · doi:10.1227/01.neu.0000249192.30786.67 · Cited by 26
Novel approaches for quantifying protein biomarkers in gliomas: benefits and pitfalls
Dahlrot, R. H., S⊘rensen, M. D., Rosager, A. M., Hellwege, S., Bangs⊘, J. A., Rosenberg, T., Petterson, S. A., Klitkou, J., Fosmark, D. S., Hansen, S., et al. (2014) · CNS Oncology · doi:10.2217/cns.14.30 · Cited by 10
Self-citationShift of microRNA profile upon orthotopic xenografting of glioblastoma spheroid cultures
Halle, B., Thomassen, M., Venkatesan, R. N., Kaimal, V., Marcusson, E. G., Munthe, S., Sørensen, M. D., Aaberg-Jessen, C., Jensen, S. S., Meyer, M., et al. (2016) · Journal of Neuro-Oncology · doi:10.1007/s11060-016-2125-x · Cited by 8
Self-citation
Cited by
Targeting tumor-associated macrophages in cancer
Pathria, P., Louis, T. L., & Varner, J. A. (2019) · Trends in Immunology · doi:10.1016/j.it.2019.02.003 · Cited by 933
Nanocarrier-based drug combination therapy for glioblastoma
Zhao, M., van Straten, D., Broekman, M. L. D., Préat, V., & Schiffelers, R. M. (2020) · Theranostics · doi:10.7150/thno.38147 · Cited by 373
Microglia/Brain Macrophages as Central Drivers of Brain Tumor Pathobiology
Gutmann, D. H., & Kettenmann, H. (2019) · Neuron · doi:10.1016/j.neuron.2019.08.028 · Cited by 295
Brain macrophage development, diversity and dysregulation in health and disease
Silvin, A., Qian, J., & Ginhoux, F. (2023) · Cellular & Molecular Immunology · doi:10.1038/s41423-023-01053-6 · Cited by 137
Role of Macrophages in Brain Tumor Growth and Progression
Guadagno, E., Presta, I., Maisano, D., Donato, A., Pirrone, C., Cardillo, G., Corrado, S., Mignogna, C., Mancuso, T., Donato, G., et al. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19041005 · Cited by 118
Metadata
- Authors
- Sørensen, M. D., Dahlrot, R. H., Boldt, H. B., Hansen, S., & Kristensen, B. W.
- Venue
- Neuropathology and Applied Neurobiology
- Publisher
- Wiley
- Published
- 2017-09-05
- Volume
- 44
- Issue
- 2
- Pages
- 185-206
- ISSN
- 0305-1846 (ISSN-L)
- 1365-2990
- OpenAlex
- W2740090202
- Cited by
- 273
- References
- 92
- FWCI
- 7.76
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.